Heron Pharma showcases expertise at CPhI China 2020
US accounts for 47% and Europe accounts for 31% of the global veterinary market. China's animal health products industry is growing stably, but still highly dispersed. The pet drug market is developing rapidly, which increased from CNY 0.73 to 1.22 billion from 2014 to 2018, and is expected to reach 4.08 billion yuan in 2023. The formulation technology develops quickly to need the needs of production.
This course summarized the market situation of veterinary dosage forms and the application of 25-OH VD3 as an excellent calcium supplement in improving the reproduction of swine and poultry also enhancing the egg quality, and also introduced the wide application of pharmaceutical excipients imported from Japan and Europe in veterinary drugs, especially for injections.
Speaker Biography
Simon Zi has been engaged in the pharmaceutical excipients industry more than 15 years and served BASF, JRS and Gattefosse as business and technical tole. He has in-depth research on pharmaceutical excipients, veterinary excipients and technologies. Now as the general manager of Heron (Shanghai) Pharma, he is responsible for the sales of active pharmaceutical ingredients, drugs produced by Nanjing Heron Pharma and take the distribution of high-quality excipients from many well-known enterprises of Japan, USA and Europe, like Nikko, Lambiotte, Kerry etc.
Post time: Aug-31-2021